{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:03:30Z","timestamp":1760267010634},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T00:00:00Z","timestamp":1271635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T00:00:00Z","timestamp":1271635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/bmt.2010.88","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T11:18:48Z","timestamp":1271675928000},"page":"238-243","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A single-nucleotide polymorphism of the Fc\u03b3 receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies"],"prefix":"10.1038","volume":"46","author":[{"given":"A","family":"Takami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Sao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Japan Marrow Donor Program","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,19]]},"reference":[{"key":"BFbmt201088_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005; 36: 757\u2013769.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201088_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2141.2004.05216.x","volume":"127","author":"AM Dickinson","year":"2004","unstructured":"Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E . Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 2004; 127: 479\u2013490.","journal-title":"Br J Haematol"},{"key":"BFbmt201088_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/sj.bmt.1705980","volume":"41","author":"AH Elmaagacli","year":"2008","unstructured":"Elmaagacli AH, Koldehoff M, Landt O, Beelen DW . Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant 2008; 41: 821\u2013826.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201088_CR4","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.bbmt.2008.08.002","volume":"14","author":"A Gerbitz","year":"2008","unstructured":"Gerbitz A, Hillemanns P, Schmid C, Wilke A, Jayaraman R, Kolb HJ et al. Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 1180\u20131189.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201088_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/01.tp.0000284583.15810.6e","volume":"84","author":"DH Kim","year":"2007","unstructured":"Kim DH, Jung HD, Lee NY, Sohn SK . Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation. Transplantation 2007; 84: 917\u2013925.","journal-title":"Transplantation"},{"key":"BFbmt201088_CR6","first-page":"5","volume":"12","author":"MR Noori-Daloii","year":"2007","unstructured":"Noori-Daloii MR, Rashidi-Nezhad A, Izadi P, Hossein-Nezhad A, Sobhani M, Derakhshandeh-Peykar P et al. Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population. Ann Transplant 2007; 12: 5\u201310.","journal-title":"Ann Transplant"},{"key":"BFbmt201088_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-3083.2007.02021.x","volume":"66","author":"DO Viel","year":"2007","unstructured":"Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC et al. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scand J Immunol 2007; 66: 703\u2013710.","journal-title":"Scand J Immunol"},{"key":"BFbmt201088_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12185-008-0061-z","volume":"87","author":"K Sugimoto","year":"2008","unstructured":"Sugimoto K, Murata M, Onizuka M, Inamoto Y, Terakura S, Kuwatsuka Y et al. Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype. Int J Hematol 2008; 87: 451\u2013458.","journal-title":"Int J Hematol"},{"key":"BFbmt201088_CR9","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3324\/haematol.2009.008318","volume":"94","author":"JL Espinoza","year":"2009","unstructured":"Espinoza JL, Takami A, Onizuka M, Sao H, Akiyama H, Miyamura K et al. NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies. Haematologica 2009; 94: 1427\u20131434.","journal-title":"Haematologica"},{"key":"BFbmt201088_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","volume":"24","author":"F Nimmerjahn","year":"2006","unstructured":"Nimmerjahn F, Ravetch JV . Fcgamma receptors: old friends and new family members. Immunity 2006; 24: 19\u201328.","journal-title":"Immunity"},{"key":"BFbmt201088_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV . Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8: 34\u201347.","journal-title":"Nat Rev Immunol"},{"key":"BFbmt201088_CR12","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","volume":"114","author":"A Shimabukuro-Vornhagen","year":"2009","unstructured":"Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS . The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009; 114: 4919\u20134927:blood-2008-10-161638.","journal-title":"Blood"},{"key":"BFbmt201088_CR13","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1046\/j.1523-1747.2002.19527.x","volume":"119","author":"K Cauza","year":"2002","unstructured":"Cauza K, Grassauer A, Hinterhuber G, Horvat R, Rappersberger K, Wolff K et al. FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. J Invest Dermatol 2002; 119: 1074\u20131079.","journal-title":"J Invest Dermatol"},{"key":"BFbmt201088_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-1759(00)00240-4","volume":"242","author":"FG Leppers-van de Straat","year":"2000","unstructured":"Leppers-van de Straat FG, van der Pol WL, Jansen MD, Sugita N, Yoshie H, Kobayashi T et al. A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping. J Immunol Methods 2000; 242: 127\u2013132.","journal-title":"J Immunol Methods"},{"key":"BFbmt201088_CR15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","volume":"90","author":"HR Koene","year":"1997","unstructured":"Koene HR, Kleijer M, Algra J, Roos D, von dem Borne AE, de Haas M . Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48\u2009L\/R\/H phenotype. Blood 1997; 90: 1109\u20131114.","journal-title":"Blood"},{"key":"BFbmt201088_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1172\/JCI119616","volume":"100","author":"J Wu","year":"1997","unstructured":"Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059\u20131070.","journal-title":"J Clin Invest"},{"key":"BFbmt201088_CR17","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/art.21266","volume":"52","author":"Z Tutuncu","year":"2005","unstructured":"Tutuncu Z, Kavanaugh A, Zvaifler N, Corr M, Deutsch R, Boyle D . Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents. Arthritis Rheum 2005; 52: 2693\u20132696.","journal-title":"Arthritis Rheum"},{"key":"BFbmt201088_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1046\/j.1365-2141.2001.02807.x","volume":"113","author":"CB Foster","year":"2001","unstructured":"Foster CB, Zhu S, Erichsen HC, Lehrnbecher T, Hart ES, Choi E et al. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol 2001; 113: 596\u2013599.","journal-title":"Br J Haematol"},{"key":"BFbmt201088_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1182\/blood.V99.3.754","volume":"99","author":"G Cartron","year":"2002","unstructured":"Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 2002; 99: 754\u2013758.","journal-title":"Blood"},{"key":"BFbmt201088_CR20","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","volume":"21","author":"WK Weng","year":"2003","unstructured":"Weng WK, Levy R . Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 2003; 21: 3940\u20133947.","journal-title":"J Clin Oncol"},{"key":"BFbmt201088_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1365-2249.1999.00984.x","volume":"117","author":"N Sugita","year":"1999","unstructured":"Sugita N, Yamamoto K, Kobayashi T, Van Der Pol W, Horigome T, Yoshie H et al. Relevance of Fc gamma RIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients. Clin Exp Immunol 1999; 117: 350\u2013354.","journal-title":"Clin Exp Immunol"},{"key":"BFbmt201088_CR22","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6","volume":"43","author":"HM Dijstelbloem","year":"2000","unstructured":"Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD et al. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 2000; 43: 2793\u20132800.","journal-title":"Arthritis Rheum"},{"key":"BFbmt201088_CR23","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1200\/JCO.2006.08.8021","volume":"25","author":"W Zhang","year":"2007","unstructured":"Zhang W, Gordon M, Schultheis AM, Yang DY, Nagashima F, Azuma M et al. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. J Clin Oncol 2007; 25: 3712\u20133718.","journal-title":"J Clin Oncol"},{"key":"BFbmt201088_CR24","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood-2007-02-072405","volume":"110","author":"T Kawase","year":"2007","unstructured":"Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235\u20132241.","journal-title":"Blood"},{"key":"BFbmt201088_CR25","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","volume":"339","author":"T Sasazuki","year":"1998","unstructured":"Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998; 339: 1177\u20131185.","journal-title":"N Engl J Med"},{"key":"BFbmt201088_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1050-3862(98)00019-9","volume":"14","author":"KJ Livak","year":"1999","unstructured":"Livak KJ . Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay. Genet Anal 1999; 14: 143\u2013149.","journal-title":"Genet Anal"},{"key":"BFbmt201088_CR27","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201088_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt201088_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","volume":"40","author":"L Scrucca","year":"2007","unstructured":"Scrucca L, Santucci A, Aversa F . Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007; 40: 381\u2013387.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201088_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BFbmt201088_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00251-003-0574-9","volume":"55","author":"WL van der Pol","year":"2003","unstructured":"van der Pol WL, Jansen MD, Sluiter WJ, van de Sluis B, Leppers-van de Straat FG, Kobayashi T et al. Evidence for non-random distribution of Fcgamma receptor genotype combinations. Immunogenetics 2003; 55: 240\u2013246.","journal-title":"Immunogenetics"},{"key":"BFbmt201088_CR32","first-page":"289","volume":"16","author":"KR Schultz","year":"1995","unstructured":"Schultz KR, Paquet J, Bader S, HayGlass KT . Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant 1995; 16: 289\u2013295.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201088_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.bbmt.2006.06.013","volume":"12","author":"R Kamble","year":"2006","unstructured":"Kamble R, Oholendt M, Carrum G . Rituximab responsive refractory acute graft-versus-host disease. Biol Blood Marrow Transplant 2006; 12: 1201\u20131202.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201088_CR34","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2005-09-3623","volume":"107","author":"C Zhang","year":"2006","unstructured":"Zhang C, Todorov I, Zhang Z, Liu Y, Kandeel F, Forman S et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006; 107: 2993\u20133001.","journal-title":"Blood"},{"key":"BFbmt201088_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","volume":"108","author":"C Cutler","year":"2006","unstructured":"Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756\u2013762.","journal-title":"Blood"},{"key":"BFbmt201088_CR36","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1182\/blood-2006-04-016063","volume":"108","author":"V Rowe","year":"2006","unstructured":"Rowe V, Banovic T, MacDonald KP, Kuns R, Don AL, Morris ES et al. Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. Blood 2006; 108: 2485\u20132492.","journal-title":"Blood"},{"key":"BFbmt201088_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.V98.2.489","volume":"98","author":"J Storek","year":"2001","unstructured":"Storek J, Wells D, Dawson MA, Storer B, Maloney DG . Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 489\u2013491.","journal-title":"Blood"},{"key":"BFbmt201088_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07574.x","volume":"145","author":"D Michonneau","year":"2009","unstructured":"Michonneau D, Peffault de Latour R, Porcher R, Robin M, Benbunan M, Rocha V et al. Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants. Br J Haematol 2009; 145: 107\u2013114.","journal-title":"Br J Haematol"},{"key":"BFbmt201088_CR39","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V95.7.2386","volume":"95","author":"TL Lehrnbecher","year":"2000","unstructured":"Lehrnbecher TL, Foster CB, Zhu S, Venzon D, Steinberg SM, Wyvill K et al. Variant genotypes of Fcgamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men. Blood 2000; 95: 2386\u20132390.","journal-title":"Blood"},{"key":"BFbmt201088_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF02983793","volume":"78","author":"JL Ferrara","year":"2003","unstructured":"Ferrara JL, Cooke KR, Teshima T . The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181\u2013187.","journal-title":"Int J Hematol"},{"key":"BFbmt201088_CR41","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nm0602-575","volume":"8","author":"T Teshima","year":"2002","unstructured":"Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke KR et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575\u2013581.","journal-title":"Nat Med"},{"key":"BFbmt201088_CR42","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1046\/j.1523-1747.2002.19527.x","volume":"119","author":"K Cauza","year":"2002","unstructured":"Cauza K, Grassauer A, Hinterhuber G, Horvat R, Rappersberger K, Wolff K et al. Fc[gamma]RIII expression on cultured human keratinocytes and upregulation by interferon-[gamma]. J Invest Dermatol 2002; 119: 1074\u20131079.","journal-title":"J Invest Dermatol"},{"key":"BFbmt201088_CR43","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1200\/JCO.2008.19.4118","volume":"26","author":"J Lejeune","year":"2008","unstructured":"Lejeune J, Thibault G, Ternant D, Cartron G, Watier H, Ohresser M . Evidence for linkage disequilibrium between Fcgamma RIIIa-V158F and Fcgamma RIIa-H131R polymorphisms in white patients, and for an Fcgamma RIIIa-restricted influence on the response to therapeutic antibodies. J Clin Oncol 2008; 26: 5489\u20135491.","journal-title":"J Clin Oncol"},{"key":"BFbmt201088_CR44","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2002-04-1033","volume":"100","author":"V Rocha","year":"2002","unstructured":"Rocha V, Franco RF, Porcher R, Bittencourt H, Silva Jr WA, Latouche A et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908\u20133918.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201088","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:31:42Z","timestamp":1648042302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,19]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFbmt201088"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.88","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2010,4,19]]},"assertion":[{"value":"7 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}